Nitrates in Aortic Stenosis Management

Introduction to Nitrates in Aortic Stenosis

The American College of Cardiology suggests that nitrates can be used cautiously in patients with aortic stenosis, particularly for acute pulmonary edema, but require careful blood pressure monitoring and should be avoided when systolic blood pressure is below 90 mmHg 1, 2

Nitrates should NOT be administered when systolic blood pressure is <90 mmHg, as this may reduce central organ perfusion, according to the American Heart Association 1, 2
For systolic blood pressure between 90-110 mmHg, nitrates should be used with extreme caution and consideration of alternative therapies, as recommended by the European Society of Cardiology 1, 2
Nitrates are recommended for patients with systolic blood pressure >110 mmHg presenting with acute decompensated heart failure, as suggested by the American College of Cardiology 1

For acute pulmonary edema with aortic stenosis, the European Society of Cardiology recommends beginning with intravenous isosorbide dinitrate at 1-10 mg/h with careful titration based on blood pressure response 1
Continuous monitoring of blood pressure, heart rate, respiratory rate, and oxygen saturation is mandatory in patients with acute pulmonary edema and aortic stenosis, as stated by the American Heart Association 1
The American College of Cardiology suggests considering arterial line placement for more precise monitoring in patients with borderline blood pressure 1
Target a reduction of approximately 10 mmHg in mean arterial pressure when using nitrates in patients with acute pulmonary edema and aortic stenosis, as recommended by the European Society of Cardiology 1

Nitrates reduce left ventricular end-diastolic pressure through venodilation and decreased preload, which can improve valvulo-arterial impedance and reduce left ventricular work, according to the European Journal of Heart Failure 3
The concern in aortic stenosis is that patients have a fixed obstruction to left ventricular outflow, making them sensitive to preload reduction, which could potentially compromise cardiac output across the stenotic valve, as noted by the American College of Cardiology 2

Nitrates are contraindicated in patients with systolic blood pressure <90 mmHg or ≥30 mmHg below baseline, as stated by the Journal of the American College of Cardiology 4
Nitrates are contraindicated in patients with severe bradycardia (<50 bpm) or tachycardia (>100 bpm) in the absence of symptomatic heart failure, according to the American Heart Association 4
Nitrates are contraindicated in patients with right ventricular infarction, as recommended by the American College of Cardiology 4, 1
Nitrates are contraindicated in patients with recent phosphodiesterase inhibitor use (within 24 hours for sildenafil, 48 hours for tadalafil), as stated by the Journal of the American College of Cardiology 4, 5

Loop diuretics should be used cautiously in severe aortic stenosis with left ventricular hypertrophy and small ventricular cavities, as abrupt changes in intravascular volume may result in significant hypotension, according to the European Journal of Heart Failure 3
Exercise extreme caution when combining nitrates with ACE inhibitors or ARBs, as the combination may potentiate hypotension, as recommended by the American College of Cardiology 2
Efficacy of nitrates may diminish after 16-24 hours due to tachyphylaxis; consider transitioning to oral nitrates with a nitrate-free interval after stabilization, as suggested by the American Heart Association 1
The role of nitrates in chronic aortic stenosis management remains unclear, though ill-effects are probably more theoretical than proven, according to the European Journal of Heart Failure 3

The Society of Cardiovascular Computed Tomography issues a strong consensus recommendation that nitroglycerin is contraindicated in patients with significant aortic stenosis. 6
The American College of Cardiology and European Society of Cardiology define an absolute contraindication when a patient’s systolic blood pressure is ≥30 mmHg below their baseline value, reflecting a high risk of hemodynamic collapse. 7
The American College of Cardiology and European Society of Cardiology also list recent phosphodiesterase‑5 inhibitor use (within 24 h for sildenafil or 48 h for tadalafil) as an absolute contraindication to nitrate therapy in aortic stenosis. 8

The American Heart Association states that nitrates are contraindicated in right‑ventricular infarction because preload reduction can precipitate catastrophic hypotension—a physiologic principle that similarly applies to severe aortic stenosis. [8][7]